The five readings

1. The Nobel Assembly, "Mature Cells Can Be Reprogrammed to Become Pluripotent"

The scientific background for the 2012 Nobel Prize in Physiology or Medicine, awarded to John Gurdon and Shinya Yamanaka.

• Claim: specialization is reversible; a mature cell's genome retains all the information needed to make any cell type.
• Evidence: Gurdon's nuclear transfer in frogs produced normal tadpoles from the nucleus of a specialized cell. Yamanaka narrowed a list of candidate genes to four transcription factors that convert fibroblasts into pluripotent cells.
• Why it matters: iPSCs give patient-specific pluripotent cells without embryos, enabling disease modeling and the organoid work in Lecture 10.
• Does not establish: that reprogrammed cells are safe or effective as therapy.

2. Paul Shapiro, Clean Meat (excerpts)

Journalistic account of the cultivated-meat field: the people, companies and obstacles.

• Claim: growing meat from cells is technically possible and could displace animal agriculture.
• Evidence: early proof-of-concept work, notably the first cultured hamburger, and the companies pursuing it.
• Read it for: the gap between a demonstration and a product. The first burger cost on the order of hundreds of thousands of dollars, which illustrates the scale-up and cost problems from Lecture 9 better than any diagram.
• Does not establish: that cultivated meat will be affordable, environmentally better, or accepted by consumers. The book is advocacy-leaning, so separate its scientific claims from its optimism.

3. Alison Abbott, Nature news feature on brain organoids

• Claim: organoids and assembloids are opening up human brain development to experiment in ways animal models cannot.
• Evidence: organoids form the cell types of real brain tissue and follow human developmental sequences; neurons mature on a slow, human-specific schedule that persists in culture, pointing to an intrinsic cellular "timer"; assembloids let researchers watch cells migrate between fused regions and test whether circuits form across them.
• Also reports: disease applications, including Zika's effect on neural progenitors and patient-derived models of neurodevelopmental conditions.
• Does not establish: that organoids reproduce a functioning brain. Abbott reports the field's own stated limits: no blood supply, immaturity, variability, missing cell types.

4. Neuralink, "PRIME Study Progress Update"

• Claim: the implant is safe so far and the first participant can control a computer by thought.
• Evidence: the participant used a cursor for games, browsing and other applications; performance was measured in bits per second.
• The key episode: threads retracted in the weeks after surgery, reducing effective electrodes and performance; software changes to recording, decoding and the interface restored and then exceeded the earlier performance.
• Does not establish: long-term implant stability, benefit across patients, or any repair of the spinal injury. Note also that this is a company reporting on its own trial, with no control group and one participant at the time of writing.

5. Annie Jacobsen, Biological War: A Scenario (excerpts)

• What it is: a constructed hypothetical, built from interviews and historical research, of how an engineered-pathogen event could unfold and how fast institutions could fail. The scenario format is a planning tool, not a prediction or an experiment.
• Historical material to know: the Soviet biological weapons program and scientists who worked in it; the Asilomar conference, where researchers set safety rules for recombinant DNA work and, as Jacobsen notes, did not take up biological warfare, assuming treaty obligations would handle it.
• Read it for: why dual-use research raises oversight questions, and what biosafety containment is for in practice.
• Does not establish: that any described pathogen exists or that any specific engineered change would produce the outcomes described. Evaluate it as a reasoned scenario, and keep that separate from experimental evidence.

Sources for the three readings available online

• Alison Abbott, "Mini models of the human brain are revealing how this complex organ takes shape," Nature 652, 288–290 (8 April 2026) — your syllabus may list this under a different headline; check which Abbott piece was assigned in Populi.
• Neuralink, "PRIME Study Progress Update"
• Kim et al., "Human assembloid model of the ascending neural sensory pathway," Nature 642, 143–153 (2025) — the four-part assembloid study the organoid feature draws on